Advertisement
Original article| Volume 18, ISSUE 8, P587-592, December 2007

Download started.

Ok

Influence of the Trp64Arg polymorphism in the beta 3 adrenoreceptor gene on insulin resistance, adipocytokine response, and weight loss secondary to lifestyle modification in obese patients

  • D.A. de Luis
    Correspondence
    Corresponding author. Institute of Endocrinology and Nutrition, Medicine School, Valladolid University, C/Los perales 16, Simancas 47130, Valladolid, Spain.
    Affiliations
    Institute of Endocrinology and Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    Search for articles by this author
  • M. Gonzalez Sagrado
    Affiliations
    Institute of Endocrinology and Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    Search for articles by this author
  • R. Aller
    Affiliations
    Institute of Endocrinology and Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    Search for articles by this author
  • O. Izaola
    Affiliations
    Institute of Endocrinology and Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    Search for articles by this author
  • R. Conde
    Affiliations
    Institute of Endocrinology and Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
    Search for articles by this author
Published:September 10, 2007DOI:https://doi.org/10.1016/j.ejim.2007.04.019

      Abstract

      Background

      The aim of our study was to investigate the influence of the Trp64Arg polymorphism in the beta 3 adrenoreceptor gene on adipocytokine response, insulin resistance, and weight loss secondary to lifestyle modification (Mediterranean hypocaloric diet and exercise) in obese patients.

      Methods

      A population of 65 obese (BMI >30) non-diabetic outpatients was analyzed in a prospective way. Before and after 3 months of a lifestyle modification program, indirect calorimetry, bioimpedance, blood pressure, serial assessment of nutritional intake for 3 days via written food records, and biochemical analysis were performed. The lifestyle modification program consisted of a hypocaloric diet (1520 kcal, 52% carbohydrates, 25% lipids, and 23% proteins). The exercise program consisted of an aerobic exercise at least three times a week (60 min each). The statistical analysis was performed for Trp64/Arg64 and Arg64/Arg64 combined as a mutant group and for type Trp64/Trp64 as a wild group.

      Results

      The mean age of the study participants was 45.8±16.8 years and the mean BMI was 34.4±4.6 kg. There were 18 males (27.7%) and 47 females (72.3%). Fifty-five patients (84.6%; 15 males/40 females) had the Trp64/Trp64 genotype (wild group) and ten patients (15.4%; 3 males/7 females) had Trp64/Arg64 (mutant group). In the wild group, BMI, weight, fat mass, systolic blood pressure and waist circumference decreased. In this group, resting metabolic rate (RMR), RMR corrected by fat free mass, and VO2 increased. In the mutant group, BMI, weight, fat mass, and waist circumference decreased. A significant increase was detected in RMR and VO2 as well. No differences were detected between baseline values in the two groups. CRP levels were higher in the mutant group than in the wild variants. No differences were detected in other parameters. Only leptin levels decreased significantly in both the wild group (10.1%; p<0.05) and the mutant group (13.6; p<0.05).

      Conclusion

      This study showed that the beneficial effect of mild weight reduction by a low caloric diet and exercise program is the greatest in subjects with a normal homozygote beta 3 adrenoreceptor gene.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kopelman P.G.
        Obesity as a medical problem.
        Nature. 2000; 404: 635-643
        • Rosenbaum M.
        • Leibel R.L.
        • Hirsh J.
        Medical progress: obesity.
        NEJM. 1997; 337: 396-407
        • Thomas G.N.
        • Tomlinson B.
        • Chang J.C.N.
        • Young R.P.
        • Critchley J.A.J.H.
        The Trp64Arg polymorphism of the beta 3 adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome.
        Int J Obes Relat Metab Disord. 2000; 25: 545-551
        • Tchernorft A.
        • Starling R.D.
        • Walston J.D.
        • Shudiner A.R.
        • Dvorack R.
        • Silver K.
        • et al.
        Obesity related phenotypes and the beta3 adrenoreceptor gene variant in postmenopausal women.
        Diabetes. 1999; 48: 1425-1428
        • Matsuda M.
        • Shimomura I.
        • Sata M.
        Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis.
        J Biol Chem. 2002; 277: 37487-37491
        • Kumada M.
        • Kihara S.
        • Sumitsuji S.
        Association of hypoadiponectinemia with coronary artery disease in men.
        Arterioscler Thromb Vasc Biol. 2003; 23: 85-89
        • Shimomoura I.
        • Hammer R.E.
        • Ikemoto S.
        Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.
        Nature. 1999; 401: 73-76
        • Steppan C.M.
        • Bailey S.T.
        • Bhat S.
        The hormone resistin links obesity to diabetes.
        Nature. 2001; 409: 307-312
        • Knowler W.C.
        • Barret-Connor E.
        • Fowler S.E.
        • Diabetes Prevention Program Research Group
        Reduction in incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        • Mathews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • Naylor B.A.
        • Treacher D.F.
        Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-414
        • Feurer I.D.
        • Mullen J.L.
        Bedside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry.
        Nutr Clin Pract. 1986; 1: 43-49
        • Pichard C.
        • Slosman D.
        • Hirschel B.
        • Kyle U.
        Bioimpedance analysis in AIDS patients: an improved method for nutritional follow up.
        Clin Res. 1993; 41: 53a
        • Mataix J.
        • Mañas M.
        Tablas de composición de alimentos españoles.
        Ed, University of Granada1998
        • Yoshida T.
        • Sakane N.
        • Umekawa T.
        • Sakai Y.
        • Takahashi T.
        • Kondo M.
        Mutation of beta 3 adrenoreceptor gene and response to treatment of obesity.
        Lancet. 1995; 346: 1433-1444
        • Urhammer S.A.
        • Clausen J.O.
        • Hansen T.
        • Pedersen O.
        Insulin sensitivity and body weight changes in young white carriers of the codon 64 amino acid polymorphism of the beta 3 adrenergic recetor gene.
        Diabetes. 1996; 45: 1115-1120
        • Sakane N.
        • Yoshida T.
        • Umekawa T.
        • Kogure A.
        • Takakura Y.
        • Kondo M.
        Effects of Trp64Arg mutation in the beta 3 adrenoreceptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients.
        Diabetes Care. 1997; 20: 1887-1992
        • Susulic V.S.
        • Frederich R.C.
        • Lawitts J.
        • Tozzo E.
        • Kahn B.B.
        • Harper M.E.
        • et al.
        Targeted disruption of the beta 3 adrenergic receptor gene.
        Endocrinology. 1995; 270: 29483-29492
        • Hoffstedt J.
        • Wahrenberg H.
        • Thome A.
        • Lönnqvist F.
        The metabolic syndrome is related to beta 3 adrenoreceptor sensitivity in visceral adipose tissue.
        Diabetología. 1996; 39: 838-844
        • Kim O.Y.
        • Cho E.Y.
        • Park H.Y.
        • Jang Y.
        • Lee J.H.
        Additive effect of the mutations in the beta 3 adrenoreceptor gene and UCP3 gene promoter on body fat distribution and glycemic control after weight reduction in overweight subjects with CAD or metabolic syndrome.
        Int J Obes. 2004; 28: 434-441
        • Widen E.
        • Lehto M.
        • Kanninen T.
        • Waltson J.
        • Schuldiner A.R.
        • Groop L.C.
        Association of a polymorphism in the beta 3 adrenoreceptor gene with features of the insulin resistance syndrome in Finns.
        New Engl J Med. 1995; 333: 348-351
        • Kadowaki H.
        • Yasuda K.
        • Iwamoto K.
        A mutation in the beta 3 adrenoreceptor gene is associated with obsesity and hyperinsulinemia in Japanese subjects.
        Biochem Biophys Res Commun. 1995; 215: 555-560
        • Sihla J.
        • Krsek M.
        • Skrha J.V.
        • Sucharda P.
        • Nyomba B.L.G.
        • Murphy L.J.
        Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance.
        Eur J Endocrinol. 2003; 149: 331-335
        • Ceddia R.B.
        • Koinstinen H.A.
        • Zierath J.R.
        • Sweeney G.
        Analysis of paradoxical observations on the association between leptin and insulin resistance.
        FASEB J. 2002; 16: 1163-1176
        • Vendrell J.
        • Gutierrez C.
        • Broch M.
        • Fernandez Real J.M.
        • Agilar C.
        • Richart C.
        Beta 3 adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients.
        Clin Endocrinol. 1998; 49: 679-683
        • De Souza C.J.
        • Hirshman M.F.
        • Horton E.S.
        CL-316243, a specific beta 3 adrenoreceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.
        Diabetes. 1997; 46: 1257-1263
        • Baron A.D.
        • Brechtel-Hook G.
        • Johnson A.
        • Cronin J.
        Effect of perfusion rate on the time course of insulin mediated skeletal muscle glucose uptake.
        Am J Physiol. 1996; 271: 1067-1072